FdaApplication
ANDA 212362
Identifiers
- fda_app_no: ANDA212362
Properties
| Property | Value |
|---|---|
| applicant_name | MSN LABS PVT LTD |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 25MG/1000MG | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG/1000MG | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG/1000MG | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 10MG/1000MG | TABLET, EXTENDED RELEASE;ORAL |
4 products